Applications:

SAS and Phase Forward Announce Product Integration

SAS will develop an interface for the SAS Drug Development biomedical informatics platform to operate with Phase Forward's clinical data management system, the Clintrial solution. The combined solution will streamline, automate and simplify the process of collecting, cleaning and analyzing clinical trials data. This will shorten the time to market for drug development by increasing clinical throughput and reducing development costs.

"Pharmaceutical companies need to reduce the number of disparate, fragmented systems and implement standardized processes with clinical R&D operations," said Steve Shaha, CEO of the Institute for Integrated Outcomes, a technology analyst firm that specializes in the pharmaceutical industry. "These two challenges remain major roadblocks to the efficiencies needed to succeed in the evolving industry. This alliance represents a genuine breakthrough in enabling pharmaceutical companies to break out of archaic and confining systems for faster, more cost-effective processing."

Aggregating validated clinical data from multiple sources, such as electronic data capture systems, in-house clinical data management systems (CDMS) and labs, is a difficult and time-consuming process. By using the SAS Drug Development platform, customers can integrate data easily from the Clintrial system and disparate sources into a common information repository, where researchers can quickly analyze single- or multi-study data to gain greater insight into their drug development program. This means that customers can more thoroughly analyze data earlier in the research process and stop research programs faster, redirect efforts, or make the decision to maintain course.

The joint offering also builds in a level of regulatory compliance that is typically absent or addressed only through time-consuming paperwork. In building a defined interface for the transmission and maintenance of electronic records between these two compliance-enabling solutions, the integrity of this data transfer will be documented automatically.

"This alliance provides the integrated technology for accelerating research in the pharmaceutical industry, saving companies money and bringing drugs to market faster," said Zul Abbany, vice president of alliance development at SAS. "Phase Forward's CDMS solutions bring the data in from the research sites, and SAS brings it together for analysis and submission. Customers led the charge for this alliance, which is a natural fit for both organizations and the pharmaceutical industry."

"With this integration we are taking another important step toward delivering a clinical enterprise solution for streamlining the drug development process," said Mike Ball, vice president of business development at Phase Forward. "SAS shares our customer focused approach to building and integrating technologies that deliver real-world solutions to problems facing the pharmaceutical industry."

To learn more about this strategic alliance, please visit SAS and Phase Forward at the DIA Annual Meeting, June 16-20 in Chicago, Illinois, or visit the companies at www.sas.com . and www.phaseforward.com.

About SAS

SAS is a market leader in providing a new generation of business intelligence software and services that create true enterprise intelligence. SAS solutions are used at more than 38,000 sites - including 99 of the top 100 businesses on the Fortune 500 - to develop more profitable relationships with customers and suppliers; to enable better, more accurate and informed decisions; and to drive organizations forward. SAS is the only vendor that completely integrates leading data warehousing, analytics and traditional BI applications to create intelligence from massive amounts of data.

About Phase Forward

Phase Forward Incorporated, a leading provider of clinical and safety data management solutions for drug development, is dedicated to helping pharmaceutical, biotechnology and medical device companies bring needed drugs and therapies to market faster. The company offers proven solutions in electronic data capture (EDC), clinical data management (CDM), electronic patient diary, and adverse event reporting (AER) as either an integrated solution or as stand-alone applications based on each customer's specific needs. Phase Forward's technologies and services have been used by customers worldwide to reduce the cost of drug and device development and improve patient safety. Phase Forward Incorporated is headquartered in Waltham, Massachusetts with international offices in the United Kingdom, Australia, France and Japan.